Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-02-01
2005-02-01
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007200, C536S007300, C536S007400
Reexamination Certificate
active
06849608
ABSTRACT:
A macrolide antibiotic of the formulawherein the variables are defined as described herein.
REFERENCES:
patent: 25937 (1859-02-01), Wu
patent: 40007 (1863-04-01), Kaneko
patent: 61856 (1867-05-01), Wu
patent: 61857 (1867-05-01), Wu
patent: 100518 (1870-05-01), Wu et al.
patent: 156027 (1874-10-01), McMillan et al.
patent: 3923784 (1975-12-01), Kierstead et al.
patent: 4474768 (1984-10-01), Bright
patent: 4517359 (1985-05-01), Kobrehel et al.
patent: 5141926 (1992-08-01), Weber et al.
patent: 5523399 (1996-06-01), Asaka et al.
patent: 5631354 (1997-05-01), Asaka et al.
patent: 5804565 (1998-09-01), Asaka et al.
patent: 6022965 (2000-02-01), Benedetti et al.
patent: 6025350 (2000-02-01), Masamune et al.
patent: 6096714 (2000-08-01), Agouridas et al.
patent: 6159945 (2000-12-01), Wu
patent: 6162794 (2000-12-01), Wu
patent: 6191118 (2001-02-01), Asaka et al.
patent: 6248719 (2001-06-01), Wu
patent: 6291656 (2001-09-01), Wu
patent: 6498146 (2002-12-01), Wu
patent: 6518251 (2003-02-01), Cheng et al.
patent: 2126665 (1993-07-01), None
patent: 0619320 (1997-05-01), None
patent: 1044985 (2000-10-01), None
patent: WO 9911651 (1999-03-01), None
patent: WO 9921869 (1999-05-01), None
patent: WO 9921870 (1999-05-01), None
patent: WO 9935157 (1999-07-01), None
patent: WO 0044761 (2000-08-01), None
patent: WO 0110878 (2001-02-01), None
patent: WO 0110880 (2001-02-01), None
Database Caplus, Chemical Abstracts Service, Columbus, OH, 1994:77599, T. Asaka, et al., “Preparation of 5-0-desosaminylerytheronolide derivatives as anitbacterial agents” XP002182602.
Database Caplus, Chemical Abstracts Service, Columbus, OH, 1999:390412, H. Kato, et al., “Preparation of erythromycin derivatives as antibacterial agents for atypical acid-fast bacterium infection” XP002182232.
Chen Yan
Su Wei-Guo
Benson Gregg C.
Forman Frank W.
Peselev Elli
Pfizer Inc.
Richardson Peter C.
LandOfFree
Macrolide antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrolide antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolide antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3488478